top of page
HOCIntelligentTechnologyGroup
AIやビッグデータ、LLM(GPT)、AIエージェントなどの先端技術と「FBLGR Quality」を掲げる研究開発は、AI in Pharma and Biotech | AI for Drug Discovery 、セキ ュリティやICTを基盤に農業・医療等のDXを推進します。さらに、未来予測やSDGsの達成に貢献し、地球規模の持続可能な開発を支える高度な人材育成を実現します。


开始使用
让我们为您的企业提供发展所需的一切。



We provide "AI solutions" that lead to fundamental problems with a small amount of data.
High-precision AI that can be used with "little data". Three features that make this happen.
Sparse modeling technology without big data
AI that can interpret "the reason for coming to that conclusion"
High speed and low power consumption. Compatible with various execution environme

With our experience in contributing to solving problems for many companies in the medical, manufacturing, and infrastructure industries, and our unique technical capabilities, we capitalize human knowledge and succeed in improving operational efficiency and labor saving. We will provide integrated support from data acquisition to linkage with existing systems, and work to realize a future where humans and AI coexist.
Diagnostic Support AI Platform
• AI to support diagnosis of cerebral infarction
• AI to support the diagnosis of hepatocellular carcinoma
• Cervical cancer diagnosis support AI
• Animal ECG measurement AI
Drug Discovery Support AI Platform
Phenotypic Screening Supported AI
Faster and clearer
AI Supports phenotypic screening
Essential cell image analysis for phenotypic screening. Solving problems that could not be solved by conventional analysis methods using sparse modeling technology. It enables us to discriminate drug effects without preconceived notions and streamline the image analysis process.
Edge AI Platform:
Lightweight and explainable AI solution for edge devices managed from the cloud


Technology Partners
• Intel Corporation
• NVIDIA Corporation



.png)





bottom of page
.png)